Skip to main content
Premium Trial:

Request an Annual Quote

New Product Watch: Oct 5, 2010

Premium

Agilent Technologies this week launched its SureSelect Kinome Target Enrichment Kit. The kit enables researchers to focus their next-generation sequencing studies on expressed kinases, the firm said.

Agilent's new assay was developed with Rene Bernards of the Netherlands Cancer Institute and targets genes for greater than 500 known kinases plus a number of cancer genes and untranslated regions. Customers can use Agilent's eArray xD tool to design custom kits.

Agilent said it has created protocols for using its new kit with sequencing instruments sold by Illumina and Life Technologies. Its SureSelect products are generally available in solution for larger studies and on arrays for smaller projects.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.